M. Johnson

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study.

A. Mocroft, O. Kirk, J. Lundgren, 2001, The Journal of infectious diseases.

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

B. Gazzard, J. Montaner, S. Staszewski, 2001, AIDS.

The SPICE Study: 48‐Week Activity of Combinations of Saquinavir Soft Gelatin and Nelfinavir With and Without Nucleoside Analogues

M. Opravil, N. Clumeck, A. Pozniak, 2000, Journal of acquired immune deficiency syndromes.

HIV Diagnosis at CD4 Count Above 500 Cells/mm3 and Progression to Below 350 Cells/mm3 Without Antiretroviral Therapy

Delpech, B. Gazzard, C. Leen, 2007, Journal of acquired immune deficiency syndromes.

A randomized, double‐blind, placebo‐controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection

D. E. Smith, M. Youle, B. Gazzard, 2001, HIV medicine.

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

P. Harrigan, S. Staszewski, C. Loveday, 1996, JAMA.

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

C. Katlama, S. Staszewski, C. Loveday, 1996, JAMA.

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

C. Kemper, M. Youle, D. Northfelt, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons.

B. Gazzard, J. Montaner, M. Youle, 2001, The Journal of infectious diseases.

CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.

C. Sabin, A. Phillips, Christine A. Lee, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

S. Hammer, J. Montaner, D. Cooper, 2001, JAMA.

HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.

R. Brookmeyer, T. Quinn, R. Bollinger, 1999, Journal of acquired immune deficiency syndromes.

Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.

P. Stone, P. Deedwania, S. Glasser, 1999, The American journal of cardiology.